Compare AdaptHealth Corp (AHCO) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Ryanair Holdings plc — how do they compare? AdaptHealth Corp trades at $5.77 (market cap $753.09M), while Ryanair Holdings plc trades at $59.52 (market cap $29.63B). The key difference: Ryanair Holdings plc is far larger — about 39.3× AdaptHealth Corp's market cap, and Ryanair Holdings plc pays a 1.51% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | RYAAY | |
|---|---|---|
Market Cap | $753.09M | $29.63B |
Sector | Health | Industrials |
52-Week High | $13.38 | $73.82 |
52-Week Low | $5.22 | $53.24 |
Enterprise Value | $2.77B | $26.61B |
Dividend Yield | — | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
RYAAY trades at $60.63, up 1.88% today, but faces a bearish technical signal with support at $58. Fundamentally, it shows strong profitability with a 12.13% net margin and a reasonable P/E of 14.37. Recent Q1 2026 earnings beat expectations despite a 34% profit decline due to lower fares and higher fuel costs (Reuters, 2026-07-20). The company maintains a robust balance sheet with $3.96B in cash and announced a strategic AI partnership with Google Cloud to enhance operations.
The outlook is mixed; analyst consensus is bullish (62.5% buy ratings), citing long-term advantages from industry consolidation and a strong financial position. However, near-term risks include volatile fuel prices, competitive fare pressures, and geopolitical tensions affecting travel demand. The stock presents a value opportunity for patient investors, but requires monitoring of operational execution amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
